Does EVOLOCUMAB Cause Rash generalised? 172 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 172 reports of Rash generalised have been filed in association with EVOLOCUMAB (REPATHA). This represents 0.1% of all adverse event reports for EVOLOCUMAB.
172
Reports of Rash generalised with EVOLOCUMAB
0.1%
of all EVOLOCUMAB reports
0
Deaths
11
Hospitalizations
How Dangerous Is Rash generalised From EVOLOCUMAB?
Of the 172 reports, 11 (6.4%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Rash generalised Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVOLOCUMAB. However, 172 reports have been filed with the FAERS database.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Rash generalised?
ADALIMUMAB (704)
ETANERCEPT (498)
LENALIDOMIDE (484)
LAMOTRIGINE (295)
AMOXICILLIN (268)
CERTOLIZUMAB PEGOL (214)
RIBAVIRIN (205)
DENOSUMAB (199)
APREMILAST (161)
SECUKINUMAB (153)
Which EVOLOCUMAB Alternatives Have Lower Rash generalised Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE